3Regulation (EC) No 1907/2006 of The European Parliament and of The Council, Official Journal of the European Union ,2006,12,30.
4Hengstler JG, Fothb H, Kahl R, et al. The REACH concept and its impact on toxicological sciences [ J ]. Toxicology,2006,220:232 - 239.
5Hartung T, Bremer S, Casati S, et al. A modular approach to the ECVAM Principles on test validity [ J ]. ATLA ,2004,32:467 -472.
6Zuang V, Hartung T. Making validated alternatives available - the strategies and work of the European centre for the validation of alternative methods (ECVAM) [J]. AATEX,2005, 11:15 -26.
7Spielmann H, Genschow E, Liebsch M, et al. Determination of the starting dose for acute oral toxicity (LD50) testing in the up and down procedure (UDP) from cytotoxicity data[ J ]. ATLA, 1999, 27:957 - 966.
8Brantom PG, Bruner LH, Chamberlain M, et al. A summary report of the COLIPA international validation study on alternatives to the Draize rabbit eye irritation test [ J ]. Toxicol In Vitro, 1997,11 : 141 - 179.
9Gettings SD, Teal J J, Bagley DM, et al. The CTFA evaluation of alternatives program: an evaluation of in vitro alternatives to the Draize primary eye irritation test (phase I) [J]. In vitro Toxicol, 1991, 4(4) : 247 - 288.
10Bails M, Berg N, Bruner LH, et al. Eye irritation testing: the way forward. Report and recommendations of ECVAM workshop 24 [ J ]. ATLA, 1999, 27:53 - 77.
